Health Tech Symposium
The Greater Manchester Local Industrial Strategy aims for the region to be the global leader on health and care innovation – creating new industries and jobs, improving population health and extending healthy life expectancy. The region is already home to a wide range of health tech companies from start-ups and university spins outs to global giants.
This half day event will comprise a range of keynotes, demos and panel discussions on themes including IP and commercialisation, selling into the NHS, building the health tech environment and supporting SMEs.
We are delighted to be able to offer NHS employees free tickets to this event - just book on using your NHS email address. There are 25 available and will be allocated on a first come, first served basis.
Sponsorship opportunities are available from just £995 +VAT. Please email Ilona Alcock for further information.
About the Speakers:
Professor Ben Bridgewater is Chief Executive of Health Innovation Manchester, an academic health science system that brings together health, academia and industry. The mission is to accelerate innovation into practice at pace and scale, so to transform the lives of Greater Manchester’s 2.8 million citizens.
He is a leading expert on health informatics, national clinical audit, clinical governance, healthcare transparency, patient experience measurement and digital transformation in healthcare, publishing numerous high profile academic outputs and delivering innovative IT tools for disseminating clinical outcomes to professionals and the public.
Prior to joining Health Innovation Manchester, Ben worked for global technology company DXC Technology as the Director of the Healthcare and Lifesciences Global Build Advisory Team. Until January 2016, he was a cardiac surgeon at the University Hospital of South Manchester for nearly 18 years.
Ben also provided clinical leadership for the UK national cardiac audit programme, as well as leading analyses that provides UK hospital and cardiac surgery mortality rates to the public. The programme is world-leading and associated with a 50% reduction in risk-adjusted mortality over 10 years.
Sarah is a freelance legal and commercial consultant working in the health sector. After 25 years as a legal advisor to the NHS, including over 10 years within the Department of Health & Social Care, Sarah set up her own consultancy business and now divides her time between providing legal support to health sector clients and advocating for improved involvement of patients in decisions about health innovations and use of health data.
She is Deputy Chair of the Public Advisory Board of Health Data Research UK and sits on the Oversight Board for the OneLondon Health LCRE. Each of these roles bring her close to some of the most interesting and ambitious plans to improve the use of and access to NHS health data.
Sarah also works with National Voices an umbrella organisation for health and care charities and it is in this role that she produced the report “Surfacing Unmet Needs – Making Innovation Work for Everyone”. The report was commissioned by NHS England/Improvement to inform decisions made by the Accelerated Access Collaborative on which innovations to prioritise for roll out across the NHS.
John Ashcroft is Chief Executive of Manchester Royal Eye Hospital and the University Dental Hospital of Manchester and under his leadership both hospitals to receive ‘Outstanding’ ratings from the Care Quality Commission.
As the youngest Chief Executive in the NHS John has over ten years’ experience of operating at executive and board level in a range of healthcare organisations and markets in both the public and private sector both across the NHS and also internationally. John has key expertise in leadership, programme management and strategy and a particular interest in working differently with industry to address the growing demands on his hospitals services
Catherine joined MIDAS as Head of Life Science in June 2019, with responsibility for defining and implementing the inward investment strategy for Greater Manchester’s Life Science sector.
She has spent her whole career within the Life Science industry starting out as a bench scientist in academic research at the University of Manchester, before making the move to her first commercial role at Applied Biosystems (now part of Thermo Fisher Scientific). Since then she has held a number of sales and marketing positions both at large Multinationals and also at SME and start-up companies, operating internationally to grow market presence.
With more than 25 years’ experience gained across both the Vitro Diagnostic and Medical Device sectors, she has a broad-spectrum appreciation of the healthcare industry having successfully commercialised and supported the introduction of new products and technologies into the NHS and overseas markets.
Catherine holds a BSc (Hons) in Microbiology from the University of Sheffield and an MBA from Bradford University.
Andrew is a successful CEO and Managing Director with extensive experience growing international technology companies. He spent many years leading complex, multi-national businesses, operating across a wide range of sectors. He specialises in the industrialisation and commercialisation of innovative technologies, business growth and turn-around.
Andrew joined The University of Manchester in mid-2016 as CEO of its subsidiary company Graphene Enabled Systems Ltd (GES). In January 2019 Andrew became CEO of The University of Manchester I 3 Ltd (UMI3), soon to be renamed the University of Manchester Innovation Factory.
Before joining GES, Andrew was Regional Managing Director of the French power equipment manufacturer Socomec SA where he led three subsidiaries covering North America and the British Isles. Prior to this, he was Sales and Marketing Director of a group business of ICI plc which manufactured a broad range of industrial and consumer products based on coated and thermally stabilised PET film.
Charlotte is a specialist commercial health lawyer at Mills & Reeve. She advises public and private healthcare organisations on a wide range of commercial and corporate matters including corporate/contractual structures, new care models and transformational programmes, as well as general commercial enquiries. She also has a particular interest in health tech and enjoys working with technology and digital companies operating in the sector.
Chair of pro-manchester’s healthcare committee, she is passionate about innovation and transformation within the sector. She loves to work with clients who are looking to break into new areas or do things differently.
Simon is a health economist and market access specialist who leads ORCHA’s scientific research department. Working in academia, the pharmaceutical and regulatory industries, his core interests include value demonstration, return on investment, and planning routes to market.
Simon has published several studies on optimising the use of digital health technologies. He is currently finalising his PhD in medical diagnostics, acts as a subject matter expect for NHS Digital, and is a content reviewer for the NIHR.
Interested In The Event?
If you’re interested in attending, you can book online here.